111. The evolution of combination immunotherapy: current successes & future goals. Issue 5 (2022) Authors: McGuigan, Roisin Journal: Immuno-oncology insights Issue: Volume 3:Issue 5(2022) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
112. The rise of next-generation T-cell engagers with better safety and efficacy. Issue 3 (2020) Authors: Vafa, Omid Journal: Immuno-oncology insights Issue: Volume 1:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
113. The use of artificial intelligence in immuno-oncology drug discovery: are we closing the gap?. Issue 5 (2021) Authors: Boutton, Carlo; Wendt, Maria Journal: Immuno-oncology insights Issue: Volume 2:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
114. To a mouse. Issue 8 (2022) Authors: McGuigan, Róisin Journal: Immuno-oncology insights Issue: Volume 3:Issue 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
115. Towards an integrated understanding of immunotherapy resistance. Issue 1 (2021) Authors: Hanks, Brent A Journal: Immuno-oncology insights Issue: Volume 2:Issue 1(2021) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
116. Translational mouse models for immuno-oncology: from syngeneic to humanized models. Issue 8 (2022) Authors: Casey, Stephanie C Journal: Immuno-oncology insights Issue: Volume 3:Issue 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
117. Understanding the evolving safety landscape in autologous and allogeneic CAR-T therapy. Issue 6 (2022) Authors: McCracken, Elaine Murray Journal: Immuno-oncology insights Issue: Volume 3:Issue 6(2022) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
118. Update on antibody–drug conjugates: where are we now, & where are we going?. Issue 5 (2022) Authors: Arnaldez, Fernanda Journal: Immuno-oncology insights Issue: Volume 3:Issue 5(2022) Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
119. Yes, IMMUcan! Unraveling the human tumor microenvironment. Issue 5 (2021) Authors: Hong, Henoch; , Robin Liechti; Morfouace, Marie Journal: Immuno-oncology insights Issue: Volume 2:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗